Kiniksa Pharmaceuticals International (KNSA) Shares Issued (2021 - 2025)
Historic Shares Issued for Kiniksa Pharmaceuticals International (KNSA) over the last 5 years, with Q3 2025 value amounting to $16.3 million.
- Kiniksa Pharmaceuticals International's Shares Issued rose 7287.52% to $16.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $34.9 million, marking a year-over-year increase of 12533.09%. This contributed to the annual value of $17.2 million for FY2024, which is 36609.02% up from last year.
- Per Kiniksa Pharmaceuticals International's latest filing, its Shares Issued stood at $16.3 million for Q3 2025, which was up 7287.52% from $12.7 million recorded in Q2 2025.
- Over the past 5 years, Kiniksa Pharmaceuticals International's Shares Issued peaked at $16.3 million during Q3 2025, and registered a low of $510000.0 during Q1 2023.
- Moreover, its 5-year median value for Shares Issued was $1.2 million (2021), whereas its average is $3.3 million.
- In the last 5 years, Kiniksa Pharmaceuticals International's Shares Issued plummeted by 7876.87% in 2022 and then soared by 102290.75% in 2025.
- Kiniksa Pharmaceuticals International's Shares Issued (Quarter) stood at $1.2 million in 2021, then grew by 6.44% to $1.3 million in 2022, then decreased by 25.81% to $957000.0 in 2023, then soared by 184.22% to $2.7 million in 2024, then surged by 497.5% to $16.3 million in 2025.
- Its Shares Issued was $16.3 million in Q3 2025, compared to $12.7 million in Q2 2025 and $3.2 million in Q1 2025.